Investor insights
Sectors invested in
Drug Development1
alpha one anti-trypsin deficiency1
Pharmaceuticals1
RNA interference1
Biotechnology1
Nanotechnology1
Health Care1
Pharmaceutical1
Drug delivery1
hepatitis B1
Biotech1
Funding rounds participated in
$9.6M sweet spot round size
Most of their 1 investments are in rounds between $9.6M and $9.6M
Basic info
Industry
biotechnology research
Sectors
Biotechnology
RNAi
Health Care
RNA Interference
Therapeutics
Medical
siRNA
Information Technology
Date founded
1999
Investments made
A
Arrowhead Pharmaceuticals, Inc. raised $9.6M on January 10, 2017
Investors: Silence Therapeutics plc
Funding rounds raised
Total raised
$46M
from 4 investors over 4 rounds
S
Silence Therapeutics plc raised $20M on November 5, 2021
Investors: Frazier Healthcare Partners
S
Silence Therapeutics plc raised $46M on February 18, 2021
Investors: Great Point Partners, Adage Capital Management and Consonance Capital